Study of TP-04 in Participants With Papulopustular Rosacea
NCT05838170
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class
Conditions
Papulopustular Rosacea
Interventions
DRUG:
Lotilaner Gel, 2.0%
OTHER:
Vehicle control gel
Sponsor
Tarsus Pharmaceuticals, Inc.